www.hczq.com 证券研究报告 | 医药生物 | 2026年2月28日 华创医药投资观点&研究专题周周谈 · 第164期 海外CXO 2025财报总结&2026年展望 本周专题联系人：王宏雨 | 华创医药团队： | | | | --- | --- | --- | | 首席分析师郑辰 | 执业编号：S0360520110002 | 邮箱：zhengchen@hcyjs.com | | 联席首席分析师刘浩 | 执业编号：S0360520120002 | 邮箱：liuhao@hcyjs.com | | 医疗器械组组长李婵娟 | 执业编号：S0360520110004 | 邮箱：lichanjuan@hcyjs.com | | 中药和流通组组长高初蕾 | 执业编号：S0360524070002 | 邮箱：gaochulei@hcyjs.com | | 高级分析师王宏雨 | 执业编号：S0360523080006 | 邮箱：wanghongyu@hcyjs.com | | 高级分析师朱珂琛 | 执业编号：S0360524070007 | 邮箱：zhukechen@hcyjs.com | | 分析师陈俊威 | 执 ...

Group 1 - The Federal Reserve is expected to lower interest rates by 25 basis points in September, with a 96.4% probability for this outcome, while a 50 basis point cut has only a 3.6% chance [2][3] - Several institutions have adjusted their forecasts for future rate cuts, with Deutsche Bank predicting three cuts by the end of 2025, and Morgan Stanley also expecting three cuts, each by 25 basis points [3] Group 2 - The impact of the Federal Reserve's rate cut on A-shares and Hong Kong stocks is anticipated through three main channels: capital flow, valuation improvement, and monetary policy adjustments [4] - A rate cut is likely to weaken the US dollar, leading to a reallocation of international funds, which may favor A-shares and Hong Kong stocks due to improving domestic fundamentals [4] - The reduction in interest rates is expected to enhance market risk appetite, potentially boosting stock market valuations and providing more room for domestic monetary policy adjustments [4] Group 3 - The sectors that may benefit from the Fed's rate cut include technology, TMT (Technology, Media, and Telecommunications), and healthcare, which have shown strong performance in previous rate cut cycles [4] - Additionally, six sectors identified as potentially experiencing a rebound include metals, consumer goods, batteries, chemicals, aquaculture, and healthcare, which have been underperforming but may see improvement with the reopening of policy space in China [8]